Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Reserve Bank of India (RBI) clarified queries raised by banks regarding the foreign currency non-resident bank (FCNR-B) deposits, especially concerning whether they can raise these deposits by ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The Reserve Bank of India (RBI) has issued detailed clarifications on its recently announced swap facility for Foreign Currency Non-Resident (Bank) or FCNR(B) deposits, allowing banks to extend loans ...

Raising interest rates on the limited period high interest rate FCNR (B) deposit scheme is only half the job for banks in their bid to attract foreign capital. The other half is answering customer ...

Julie Young is an experienced financial writer and editor. She specializes in financial analysis in capital planning and investment management. Investopedia / Mira Norian A monopsony features a single ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...